Cargando…

Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion

BACKGROUND: In patients with a C9orf72 repeat expansion (C9+), a neuroimaging phenotype with widespread structural cerebral changes has been found. We aimed to investigate the specificity of this neuroimaging phenotype in patients with amyotrophic lateral sclerosis (ALS). METHODS: 156 C9− and 14 C9+...

Descripción completa

Detalles Bibliográficos
Autores principales: Westeneng, Henk-Jan, Walhout, Renée, Straathof, Milou, Schmidt, Ruben, Hendrikse, Jeroen, Veldink, Jan H, van den Heuvel, Martijn P, van den Berg, Leonard H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136726/
https://www.ncbi.nlm.nih.gov/pubmed/27756805
http://dx.doi.org/10.1136/jnnp-2016-313959
Descripción
Sumario:BACKGROUND: In patients with a C9orf72 repeat expansion (C9+), a neuroimaging phenotype with widespread structural cerebral changes has been found. We aimed to investigate the specificity of this neuroimaging phenotype in patients with amyotrophic lateral sclerosis (ALS). METHODS: 156 C9− and 14 C9+ patients with ALS underwent high-resolution T1-weighted MRI; a subset (n=126) underwent diffusion-weighted imaging. Cortical thickness, subcortical volumes and white matter integrity were compared between C9+ and C9− patients. Using elastic net logistic regression, a model defining the neuroimaging phenotype of C9+ was determined and applied to C9− patients with ALS. RESULTS: C9+ patients showed cortical thinning outside the precentral gyrus, extending to the bilateral pars opercularis, fusiform, lingual, isthmus-cingulate and superior parietal cortex, and smaller volumes of the right hippocampus and bilateral thalamus, and reduced white matter integrity of the inferior and superior longitudinal fasciculus compared with C9− patients (p<0.05). Among 128 C9− patients, we detected a subgroup of 27 (21%) with a neuroimaging phenotype congruent to C9+ patients, while 101 (79%) C9− patients showed cortical thinning restricted to the primary motor cortex. C9− patients with a ‘C9+’ neuroimaging phenotype had lower performance on the frontal assessment battery, compared with other C9− patients with ALS (p=0.004). CONCLUSIONS: This study shows that widespread structural brain involvement is not limited to C9+ patients, but also presents in a subgroup of C9− patients with ALS and relates to cognitive deficits. Our neuroimaging findings reveal an intermediate phenotype that may provide insight into the complex relationship between genetic factors and clinical characteristics.